Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia

Cost-effectiveness analysis of budesonide/formoterol (Symbicort®) as needed for mild asthma in Malaysia

Background: Budesonide/formoterol (Symbicort®) as needed (PRN) is effective for the prevention of severe exacerbations in mild asthma. Objective: This economic model evaluated the cost effectiveness of budesonide/formoterol PRN versus (1) a short-acting β2-agonist (SABA) PRN and (2) maintenance bude...

Full description

Bibliographic Details
Main Authors: Abdullah Thani, N.S.I (Author), Neoh, C.F (Author), Raja Gopal, V. (Author), Tan, W. (Author)
Format: Article
Language:English
Published: Adis 2021
Series:Drugs and Therapy Perspectives
Subjects:
Article
asthma
budesonide
budesonide plus formoterol
cataract
child
controlled study
cost effectiveness analysis
disease duration
disease exacerbation
disease severity
drug cost
drug withdrawal
economic model
emergency ward
formoterol
glaucoma
health care cost
human
maintenance therapy
major clinical study
Malaysia
Monte Carlo method
osteoporosis
pneumonia
practice guideline
salbutamol
school child
treatment outcome
Online Access:View Fulltext in Publisher
View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Similar Items